Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells

Leukemia Research

Volumn 33, Issue 1, 2009, Pages 140-150

  Lugli, Enrico ^a   Ferraresi, Roberta ^a   Roat, Erika ^a   Troiano, Leonarda ^a   Pinti, Marcello ^a   Nasi, Milena ^a   Nemes, Elisa ^a   Bertoncelli, Linda ^a   Gibellini, Lara ^a   Salomoni, Paolo ^b   Cooper, Edwin L ^c   Cossarizza, Andrea ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b MRC TOXICOLOGY UNIT   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Leukemic cell lines; Lymphocyte function; PBMCs; Quercetin

Indexed keywords

FAS ANTIGEN; PHYTOHEMAGGLUTININ; QUERCETIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN U937; CONTROLLED STUDY; DRUG SENSITIZATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

APOPTOSIS; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; QUERCETIN; U937 CELLS;

EID: 55049133406     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.07.025     Document Type: Article

References (46)

1. Blagosklonny M.V. Overcoming limitations of natural anticancer drugs by combining with artificial agents. Trends Pharmacol. Sci. 26 (2005) 77-81
2. Stavric B. Role of chemopreventers in human diet. Clin. Biochem. 27 (1994) 319-332
3. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., and Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 66 (2006) 1234-1240
4. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5 (2006) 493-506
5. Ross J.A., and Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 22 (2002) 19-34
6. Larocca L.M., Teofili L., Sica S., Piantelli M., Maggiano N., Leone G., and Ranelletti F.O. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells. Blood 85 (1995) 3654-3661
7. Larocca L.M., Teofili L., Maggiano N., Piantelli M., Ranelletti F.O., and Leone G. Quercetin and the growth of leukemic progenitors. Leuk. Lymphoma 23 (1996) 49-53
8. Kuo S.M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110 (1996) 41-48
9. Ferrandina G., Almadori G., Maggiano N., Lanza P., Ferlini C., Cattani P., Piantelli M., Scambia G., and Ranelletti F.O. Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors. Int. J. Cancer 77 (1998) 747-754
10. Rong Y., Yang E.B., Zhang K., and Mack P. Quercetin-induced apoptosis in the monoblastoid cell line U937 in vitro and the regulation of heat shock proteins expression. Anticancer Res. 20 (2000) 4339-4345
11. Mouria M., Gukovskaya A.S., Jung Y., Buechler P., Hines O.J., Reber H.A., and Pandol S.J. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome c release and apoptosis. Int. J. Cancer 98 (2002) 761-769
12. Lugli E., Troiano L., Ferraresi R., Roat E., Prada N., Nasi M., Pinti M., Cooper E.L., and Cossarizza A. Characterization of cells with different mitochondrial membrane potential during apoptosis. Cytometry A. 68 (2005) 28-35
13. Ferraresi R., Troiano L., Roat E., Lugli E., Nemes E., Nasi M., Pinti M., Fernandez M.I., Cooper E.L., and Cossarizza A. Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic. Res. 39 (2005) 1249-1258
14. 2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. (2005)
15. Ranelletti F.O., Ricci R., Larocca L.M., Maggiano N., Capelli A., Scambia G., Benedetti-Panici P., Mancuso S., Rumi C., and Piantelli M. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int. J. Cancer 50 (1992) 486-492
16. 1 phase of the cell cycle. Cancer Res. 52 (1992) 6676-6681
17. Avila M.A., Velasco J.A., Cansado J., and Notario V. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res. 54 (1994) 2424-2428
18. Chen Y.C., Shen S.C., Chow J.M., Ko C.H., and Tseng S.W. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int. J. Oncol. 25 (2004) 661-670
19. Ferry D.R., Smith A., Malkhandi J., Fyfe D.W., deTakats P.G., Anderson D., Baker J., and Kerr D.J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2 (1996) 659-668
20. Boots A.W., Li H., Schins R.P., Duffin R., Heemskerk J.W., Bast A., and Haenen G.R. The quercetin paradox. Toxicol. Appl. Pharmacol. 222 (2007) 89-96
21. Boots A.W., Kubben N., Haenen G.R., and Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem. Biophys. Res. Commun. 308 (2003) 560-565
22. Riccardi C., and Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc. 1 (2006) 1458-1461
23. Troiano L., Ferraresi R., Lugli E., Nemes E., Roat E., Nasi M., Pinti M., and Cossarizza A. Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry. Nat. Protoc. 2 (2007) 2719-2727
24. Wang I.K., Lin-Shiau S.Y., and Lin J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukemia HL-60 cells. Eur. J. Cancer 35 (1999) 1517-1525
25. Duraj J., Zazrivcova K., Bodo J., Sulikova M., and Sedlak J. Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. Neoplasma 52 (2005) 273-279
26. Kuhar M., Sen S., and Singh N. Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells. Anticancer Res. 26 (2006) 1297-1303
27. Klas C., Debatin K.M., Jonker R.R., and Krammer P.H. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5 (1993) 625-630
28. Schattner E.J., Elkon K.B., Yoo D.H., Tumang J., Krammer P.H., Crow M.K., and Friedman S.M. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182 (1995) 1557-1565
29. Garrone P., Neidhardt E.M., Garcia E., Galibert L., van Kooten C., and Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182 (1995) 1265-1273
30. Cossarizza A., Stent G., Mussini C., Paganelli R., Borghi V., Nuzzo C., Pinti M., Pedrazzi J., Benatti F., Esposito R., Rosok B., Nagata S., Vella S., Franceschi C., and De Rienzo B. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection. AIDS 14 (2000) 345-355
31. Igura K., Ohta T., Kuroda Y., and Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 171 (2001) 11-16
32. Tan W.F., Lin L.P., Li M.H., Zhang Y.X., Tong Y.G., Xiao D., and Ding J. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur. J. Pharmacol. 459 (2003) 255-262
33. Nakadate T., Yamamoto S., Aizu E., and Kato R. Inhibition by lipoxygenase inhibitors of 7-bromomethylbenz[a]anthracene-caused epidermal ornithine decarboxylase induction and skin tumor promotion in mice. Carcinogenesis 10 (1989) 2053-2057
34. Elangovan V., Sekar N., and Govindasamy S. Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett. 87 (1994) 107-113
35. Scambia G., Ranelletti F.O., Panici P.B., De Vincenzo R., Bonanno G., Ferrandina G., Piantelli M., Bussa S., Rumi C., Cianfriglia M., and Mancuso S. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 34 (1994) 459-464
36. Jakubowicz-Gil J., Paduch R., Piersiak T., Glowniak K., Gawron A., and Kandefer-Szerszen M. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochem. Pharmacol. 69 (2005) 1343-1350
37. Monasterio A., Urdaci M.C., Pinchuk I.V., Lopez-Moratalla N., and Martinez-Irujo J.J. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutr. Cancer 50 (2004) 90-100
38. Conus S., Perozzo R., Reinheckel T., Peters C., Scapozza L., Yousefi S., and Simon H.U. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J. Exp. Med. 205 (2008) 685-698
39. Brusselmans K., Vrolix R., Verhoeven G., and Swinnen J.V. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J. Biol. Chem. 280 (2005) 5636-5645
40. Russo M., Palumbo R., Mupo A., Tosto M., Iacomino G., Scognamiglio A., Tedesco I., Galano G., and Russo G.L. Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Calpha. Oncogene. 22 (2003) 3330-3342
41. Russo M., Nigro P., Rosiello R., D'Arienzo R., and Russo G.L. Quercetin enhances CD95- and TRAIL-induced apoptosis in leukemia cell lines. Leukemia 21 (2007) 1130-1133
42. Larocca L.M., Teofili L., Leone G., Sica S., Pierelli L., Menichella G., Scambia G., Benedetti Panici P., Ricci R., Piantelli M., et al. Antiproliferative activity of quercetin on normal bone marrow and leukemic progenitors. Br. J. Haematol. 79 (1991) 562-566
43. Liesveld J.L., Abboud C.N., Lu C., McNair C., Menon A., Smith A., Rosell K., and Rapoport A.P. Flavonoid effects on normal and leukemic cells. Leuk. Res. 27 (2003) 517-527
44. Sandoval A., Consoli U., and Plunkett W. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. Clin. Cancer Res. 2 (1996) 1731-1741
45. Borner M.M., Joncourt F., and Hotz M.A. Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cells. Br. J. Cancer 76 (1997) 1448-1454
46. Ferraro C., Quemeneur L., Fournel S., Prigent A.F., Revillard J.P., and Bonnefoy-Berard N. The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes. Cell Death Differ. 7 (2000) 197-206